{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:07e067a8-43a3-4e49-a390-254524565636","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-19T09:50:50.586673+00:00","published_at":"2026-10-19T04:46:31.170154+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:wzhlne1f1xk74","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-04-27","detected_at":"2026-10-19T04:46:31.170154+00:00","subject_ids":["alpha:person:han-ying-ph-d","alpha:company:07e067a8-43a3-4e49-a390-254524565636"],"caused_claim_ids":["alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:5318b816495da93c437151a13aa393a3b17bbc9976cd78762b4a5cb1e6cfb46c"],"summary":"Han Ying, Ph.D. executive of GYRE THERAPEUTICS, INC., effective 2026-04-27.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:10o0oqh1iv72d3","event_type":"CEO_CHANGED","effective_at":"2026-04-27","detected_at":"2026-10-19T04:46:31.170154+00:00","subject_ids":["alpha:person:ping-zhang","alpha:company:07e067a8-43a3-4e49-a390-254524565636"],"caused_claim_ids":["alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:e54424b984bc05d8bfc80a77412b10927f2b89dcc0900d7e680e12c7a3c17bb9"],"summary":"Ping Zhang executive of GYRE THERAPEUTICS, INC., effective 2026-04-27.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:18j11yb1shp2e7","event_type":"CFO_CHANGED","effective_at":"2026-04-27","detected_at":"2026-10-19T04:46:31.170154+00:00","subject_ids":["alpha:person:ruoyu-chen","alpha:company:07e067a8-43a3-4e49-a390-254524565636"],"caused_claim_ids":["alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:15"],"evidence_ids":["alpha:projection-evidence:document:669cdb5b627177af8696f28464136346920dfaf3f69db870d2d97f3b3e6f69c8"],"summary":"Ruoyu Chen executive of GYRE THERAPEUTICS, INC., effective 2026-04-27.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:bt9xrs2npyza","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-04-27","detected_at":"2026-10-19T04:46:31.170154+00:00","subject_ids":["alpha:person:songjiang-ma","alpha:company:07e067a8-43a3-4e49-a390-254524565636"],"caused_claim_ids":["alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:16"],"evidence_ids":["alpha:projection-evidence:document:0586a36ab744a7968768f60217453542ddbbc4e74870299032b7ad69ece93a53"],"summary":"Songjiang Ma executive of GYRE THERAPEUTICS, INC., effective 2026-04-27.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1m7mtjyh7l0cq","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-04-27","detected_at":"2026-10-19T04:46:31.170154+00:00","subject_ids":["alpha:person:weiguo-ye","alpha:company:07e067a8-43a3-4e49-a390-254524565636"],"caused_claim_ids":["alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:17"],"evidence_ids":["alpha:projection-evidence:document:f105aa789bf5ea7313dbe076a52c63d3bf9de2b925e6bb6aa0e99eeb17cad199"],"summary":"Weiguo Ye executive of GYRE THERAPEUTICS, INC., effective 2026-04-27.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:hl1furexzj5t","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-19T04:46:31.170154+00:00","subject_ids":["alpha:person:ping-zhang","alpha:company:07e067a8-43a3-4e49-a390-254524565636"],"caused_claim_ids":["alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523"],"summary":"Ping Zhang seat on GYRE THERAPEUTICS, INC., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1nl0tp2g59nhi","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2025-01-01","detected_at":"2026-10-19T04:46:31.170154+00:00","subject_ids":["alpha:person:ping-zhang","alpha:committee:gyre-therapeutics-inc:nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:committee_record:20"],"evidence_ids":["alpha:projection-evidence:1d7bbbcc2acaf2ee9bd6596dd96ebdf8d1cdce7ea78f8eb8dbd38117a04a833b"],"summary":"Ping Zhang member of Nominating and Governance, effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:ntolf5hh1kbt","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-10-19T04:46:31.170154+00:00","subject_ids":["alpha:person:david-m-epstein-ph-d","alpha:company:07e067a8-43a3-4e49-a390-254524565636"],"caused_claim_ids":["alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523"],"summary":"David M. Epstein, Ph.D. seat on GYRE THERAPEUTICS, INC., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:5t4mr91hwy8vp","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-10-19T04:46:31.170154+00:00","subject_ids":["alpha:person:rodney-nussbaum","alpha:company:07e067a8-43a3-4e49-a390-254524565636"],"caused_claim_ids":["alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523"],"summary":"Rodney Nussbaum seat on GYRE THERAPEUTICS, INC., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:px3izbwc9fwp","event_type":"COMMITTEE_CREATED","effective_at":"2024-01-01","detected_at":"2026-10-19T04:46:31.170154+00:00","subject_ids":["alpha:committee:gyre-therapeutics-inc:audit-chair","alpha:company:07e067a8-43a3-4e49-a390-254524565636"],"caused_claim_ids":["alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523"],"summary":"Audit · Chair committee of GYRE THERAPEUTICS, INC., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:14c74hr14vhee3","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2024-01-01","detected_at":"2026-10-19T04:46:31.170154+00:00","subject_ids":["alpha:person:rodney-nussbaum","alpha:committee:gyre-therapeutics-inc:audit-chair"],"caused_claim_ids":["alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523"],"summary":"Rodney Nussbaum member of Audit · Chair, effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:9bedwb16uyott","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-19T04:46:31.170154+00:00","subject_ids":["alpha:person:gordon-carmichael-ph-d","alpha:company:07e067a8-43a3-4e49-a390-254524565636"],"caused_claim_ids":["alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523"],"summary":"Gordon Carmichael, Ph.D. seat on GYRE THERAPEUTICS, INC., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:v9bca04veyh0","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-19T04:46:31.170154+00:00","subject_ids":["alpha:person:han-ying-ph-d","alpha:company:07e067a8-43a3-4e49-a390-254524565636"],"caused_claim_ids":["alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523"],"summary":"Han Ying, Ph.D. seat on GYRE THERAPEUTICS, INC., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:hmk1hs1d4ay7q","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-19T04:46:31.170154+00:00","subject_ids":["alpha:person:renate-parry-ph-d","alpha:company:07e067a8-43a3-4e49-a390-254524565636"],"caused_claim_ids":["alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523"],"summary":"Renate Parry, Ph.D. seat on GYRE THERAPEUTICS, INC., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:pej6glkewckn","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-19T04:46:31.170154+00:00","subject_ids":["alpha:person:songjiang-ma","alpha:company:07e067a8-43a3-4e49-a390-254524565636"],"caused_claim_ids":["alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523"],"summary":"Songjiang Ma seat on GYRE THERAPEUTICS, INC., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1we55cuf2msp8","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-19T04:46:31.170154+00:00","subject_ids":["alpha:person:thomas-eastling","alpha:company:07e067a8-43a3-4e49-a390-254524565636"],"caused_claim_ids":["alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523"],"summary":"Thomas Eastling seat on GYRE THERAPEUTICS, INC., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:x0ipc21go7y90","event_type":"COMMITTEE_CREATED","effective_at":"2023-01-01","detected_at":"2026-10-19T04:46:31.170154+00:00","subject_ids":["alpha:committee:gyre-therapeutics-inc:nominating-and-governance-chair","alpha:company:07e067a8-43a3-4e49-a390-254524565636"],"caused_claim_ids":["alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523"],"summary":"Nominating and Governance · Chair committee of GYRE THERAPEUTICS, INC., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:19q3jte1e5o7vg","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2023-01-01","detected_at":"2026-10-19T04:46:31.170154+00:00","subject_ids":["alpha:person:thomas-eastling","alpha:committee:gyre-therapeutics-inc:nominating-and-governance-chair"],"caused_claim_ids":["alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523"],"summary":"Thomas Eastling member of Nominating and Governance · Chair, effective 2023-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:5","subject_id":"alpha:company:07e067a8-43a3-4e49-a390-254524565636","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:david-m-epstein-ph-d","object_label":"David M. Epstein, Ph.D.","object_source_name_forms":[],"value":"David M. Epstein, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:david-m-epstein-ph-d","name":"David M. Epstein, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-19T04:46:31.170154+00:00","sources":[{"id":"alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"GYRE THERAPEUTICS, INC. DEF 14A 2025-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036125014779/ny20044429x1_def14a.htm","source_date":"2025-04-21","retrieved_at":"2026-04-28T23:52:00.625+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-21","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-19T04:46:31.170154+00:00","reviewed_at":"2026-10-19T04:46:31.170154+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:6","subject_id":"alpha:company:07e067a8-43a3-4e49-a390-254524565636","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:gordon-carmichael-ph-d","object_label":"Gordon Carmichael, Ph.D.","object_source_name_forms":[],"value":"Gordon Carmichael, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:gordon-carmichael-ph-d","name":"Gordon Carmichael, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-19T04:46:31.170154+00:00","sources":[{"id":"alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"GYRE THERAPEUTICS, INC. DEF 14A 2025-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036125014779/ny20044429x1_def14a.htm","source_date":"2025-04-21","retrieved_at":"2026-04-28T23:52:00.625+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-21","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-19T04:46:31.170154+00:00","reviewed_at":"2026-10-19T04:46:31.170154+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:7","subject_id":"alpha:company:07e067a8-43a3-4e49-a390-254524565636","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:han-ying-ph-d","object_label":"Han Ying, Ph.D.","object_source_name_forms":[],"value":"Han Ying, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:han-ying-ph-d","name":"Han Ying, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-19T04:46:31.170154+00:00","sources":[{"id":"alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"GYRE THERAPEUTICS, INC. DEF 14A 2025-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036125014779/ny20044429x1_def14a.htm","source_date":"2025-04-21","retrieved_at":"2026-04-28T23:52:00.625+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-21","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-19T04:46:31.170154+00:00","reviewed_at":"2026-10-19T04:46:31.170154+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:8","subject_id":"alpha:company:07e067a8-43a3-4e49-a390-254524565636","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:ping-zhang","object_label":"Ping Zhang","object_source_name_forms":[],"value":"Ping Zhang: Director, Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:ping-zhang","name":"Ping Zhang"},"title":"Director","role_category":"director","committee":"Nominating and Governance","is_board_chair":false,"is_independent":false,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-19T04:46:31.170154+00:00","sources":[{"id":"alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"GYRE THERAPEUTICS, INC. DEF 14A 2025-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036125014779/ny20044429x1_def14a.htm","source_date":"2025-04-21","retrieved_at":"2026-04-28T23:52:00.625+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-21","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-19T04:46:31.170154+00:00","reviewed_at":"2026-10-19T04:46:31.170154+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:9","subject_id":"alpha:company:07e067a8-43a3-4e49-a390-254524565636","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:renate-parry-ph-d","object_label":"Renate Parry, Ph.D.","object_source_name_forms":[],"value":"Renate Parry, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:renate-parry-ph-d","name":"Renate Parry, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-19T04:46:31.170154+00:00","sources":[{"id":"alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"GYRE THERAPEUTICS, INC. DEF 14A 2025-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036125014779/ny20044429x1_def14a.htm","source_date":"2025-04-21","retrieved_at":"2026-04-28T23:52:00.625+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-21","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-19T04:46:31.170154+00:00","reviewed_at":"2026-10-19T04:46:31.170154+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:10","subject_id":"alpha:company:07e067a8-43a3-4e49-a390-254524565636","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:rodney-nussbaum","object_label":"Rodney Nussbaum","object_source_name_forms":[],"value":"Rodney Nussbaum: Director, Audit · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:rodney-nussbaum","name":"Rodney Nussbaum"},"title":"Director","role_category":"director","committee":"Audit · Chair","is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-19T04:46:31.170154+00:00","sources":[{"id":"alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"GYRE THERAPEUTICS, INC. DEF 14A 2025-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036125014779/ny20044429x1_def14a.htm","source_date":"2025-04-21","retrieved_at":"2026-04-28T23:52:00.625+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-21","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-19T04:46:31.170154+00:00","reviewed_at":"2026-10-19T04:46:31.170154+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:11","subject_id":"alpha:company:07e067a8-43a3-4e49-a390-254524565636","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:songjiang-ma","object_label":"Songjiang Ma","object_source_name_forms":[],"value":"Songjiang Ma: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:songjiang-ma","name":"Songjiang Ma"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-19T04:46:31.170154+00:00","sources":[{"id":"alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"GYRE THERAPEUTICS, INC. DEF 14A 2025-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036125014779/ny20044429x1_def14a.htm","source_date":"2025-04-21","retrieved_at":"2026-04-28T23:52:00.625+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-21","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-19T04:46:31.170154+00:00","reviewed_at":"2026-10-19T04:46:31.170154+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:12","subject_id":"alpha:company:07e067a8-43a3-4e49-a390-254524565636","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:thomas-eastling","object_label":"Thomas Eastling","object_source_name_forms":[],"value":"Thomas Eastling: Director, Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:thomas-eastling","name":"Thomas Eastling"},"title":"Director","role_category":"director","committee":"Nominating and Governance · Chair","is_board_chair":false,"is_independent":false,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-19T04:46:31.170154+00:00","sources":[{"id":"alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"GYRE THERAPEUTICS, INC. DEF 14A 2025-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036125014779/ny20044429x1_def14a.htm","source_date":"2025-04-21","retrieved_at":"2026-04-28T23:52:00.625+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-21","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-19T04:46:31.170154+00:00","reviewed_at":"2026-10-19T04:46:31.170154+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:13","subject_id":"alpha:company:07e067a8-43a3-4e49-a390-254524565636","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:han-ying-ph-d","object_label":"Han Ying, Ph.D.","object_source_name_forms":[],"value":"Han Ying, Ph.D.: Senior Vice President, Science","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:han-ying-ph-d","name":"Han Ying, Ph.D."},"title":"Senior Vice President, Science","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-27","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-27","valid_to":null,"recorded_at":"2026-10-19T04:46:31.170154+00:00","sources":[{"id":"alpha:projection-evidence:document:5318b816495da93c437151a13aa393a3b17bbc9976cd78762b4a5cb1e6cfb46c","identity_scope":"source_document_reference","source_type":"sec_filing","title":"GYRE DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126017124/ny20063852x3_def14a.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-05-16T03:26:15.136657+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":"2026-04-27","effective_until":null,"observed_at":"2026-10-19T04:46:31.170154+00:00","reviewed_at":"2026-10-19T04:46:31.170154+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:14","subject_id":"alpha:company:07e067a8-43a3-4e49-a390-254524565636","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:ping-zhang","object_label":"Ping Zhang","object_source_name_forms":[],"value":"Ping Zhang: Chief Executive Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:ping-zhang","name":"Ping Zhang"},"title":"Chief Executive Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-27","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-27","valid_to":null,"recorded_at":"2026-10-19T04:46:31.170154+00:00","sources":[{"id":"alpha:projection-evidence:document:e54424b984bc05d8bfc80a77412b10927f2b89dcc0900d7e680e12c7a3c17bb9","identity_scope":"source_document_reference","source_type":"sec_filing","title":"GYRE DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126017124/ny20063852x3_def14a.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-05-16T03:26:13.290791+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":"2026-04-27","effective_until":null,"observed_at":"2026-10-19T04:46:31.170154+00:00","reviewed_at":"2026-10-19T04:46:31.170154+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:15","subject_id":"alpha:company:07e067a8-43a3-4e49-a390-254524565636","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:ruoyu-chen","object_label":"Ruoyu Chen","object_source_name_forms":[],"value":"Ruoyu Chen: Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:ruoyu-chen","name":"Ruoyu Chen"},"title":"Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-27","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-27","valid_to":null,"recorded_at":"2026-10-19T04:46:31.170154+00:00","sources":[{"id":"alpha:projection-evidence:document:669cdb5b627177af8696f28464136346920dfaf3f69db870d2d97f3b3e6f69c8","identity_scope":"source_document_reference","source_type":"sec_filing","title":"GYRE DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126017124/ny20063852x3_def14a.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-05-16T03:26:14.134884+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":"2026-04-27","effective_until":null,"observed_at":"2026-10-19T04:46:31.170154+00:00","reviewed_at":"2026-10-19T04:46:31.170154+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:16","subject_id":"alpha:company:07e067a8-43a3-4e49-a390-254524565636","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:songjiang-ma","object_label":"Songjiang Ma","object_source_name_forms":[],"value":"Songjiang Ma: President","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:songjiang-ma","name":"Songjiang Ma"},"title":"President","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-27","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-27","valid_to":null,"recorded_at":"2026-10-19T04:46:31.170154+00:00","sources":[{"id":"alpha:projection-evidence:document:0586a36ab744a7968768f60217453542ddbbc4e74870299032b7ad69ece93a53","identity_scope":"source_document_reference","source_type":"sec_filing","title":"GYRE DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126017124/ny20063852x3_def14a.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-05-16T03:26:13.67017+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":"2026-04-27","effective_until":null,"observed_at":"2026-10-19T04:46:31.170154+00:00","reviewed_at":"2026-10-19T04:46:31.170154+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:17","subject_id":"alpha:company:07e067a8-43a3-4e49-a390-254524565636","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:weiguo-ye","object_label":"Weiguo Ye","object_source_name_forms":[],"value":"Weiguo Ye: Chief Operating Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:weiguo-ye","name":"Weiguo Ye"},"title":"Chief Operating Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-27","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-27","valid_to":null,"recorded_at":"2026-10-19T04:46:31.170154+00:00","sources":[{"id":"alpha:projection-evidence:document:f105aa789bf5ea7313dbe076a52c63d3bf9de2b925e6bb6aa0e99eeb17cad199","identity_scope":"source_document_reference","source_type":"sec_filing","title":"GYRE DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126017124/ny20063852x3_def14a.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-05-16T03:26:14.602739+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":"2026-04-27","effective_until":null,"observed_at":"2026-10-19T04:46:31.170154+00:00","reviewed_at":"2026-10-19T04:46:31.170154+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:committee_record:20","subject_id":"alpha:company:07e067a8-43a3-4e49-a390-254524565636","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Nominating and Governance: Chair Thomas Eastling; Members Thomas Eastling (Chair); Ping Zhang","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Nominating and Governance","canonical_type":"nominating_governance","chair":"Thomas Eastling","members":[{"display_name":"Thomas Eastling","person_slug":"thomas-eastling","is_chair":true},{"display_name":"Ping Zhang","person_slug":"ping-zhang","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-19T04:46:31.170154+00:00","sources":[{"id":"alpha:projection-evidence:1d7bbbcc2acaf2ee9bd6596dd96ebdf8d1cdce7ea78f8eb8dbd38117a04a833b","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036125014779/ny20044429x1_def14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-19T04:46:31.170154+00:00","reviewed_at":"2026-10-19T04:46:31.170154+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"GYRE THERAPEUTICS, INC. DEF 14A 2025-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036125014779/ny20044429x1_def14a.htm","source_date":"2025-04-21","retrieved_at":"2026-04-28T23:52:00.625+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:5318b816495da93c437151a13aa393a3b17bbc9976cd78762b4a5cb1e6cfb46c","identity_scope":"source_document_reference","source_type":"sec_filing","title":"GYRE DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126017124/ny20063852x3_def14a.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-05-16T03:26:15.136657+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:e54424b984bc05d8bfc80a77412b10927f2b89dcc0900d7e680e12c7a3c17bb9","identity_scope":"source_document_reference","source_type":"sec_filing","title":"GYRE DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126017124/ny20063852x3_def14a.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-05-16T03:26:13.290791+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:669cdb5b627177af8696f28464136346920dfaf3f69db870d2d97f3b3e6f69c8","identity_scope":"source_document_reference","source_type":"sec_filing","title":"GYRE DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126017124/ny20063852x3_def14a.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-05-16T03:26:14.134884+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:0586a36ab744a7968768f60217453542ddbbc4e74870299032b7ad69ece93a53","identity_scope":"source_document_reference","source_type":"sec_filing","title":"GYRE DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126017124/ny20063852x3_def14a.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-05-16T03:26:13.67017+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:f105aa789bf5ea7313dbe076a52c63d3bf9de2b925e6bb6aa0e99eeb17cad199","identity_scope":"source_document_reference","source_type":"sec_filing","title":"GYRE DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126017124/ny20063852x3_def14a.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-05-16T03:26:14.602739+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:1d7bbbcc2acaf2ee9bd6596dd96ebdf8d1cdce7ea78f8eb8dbd38117a04a833b","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036125014779/ny20044429x1_def14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.848,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.882,"cross_source_agreement":0.75,"temporal_completeness":0.813},"diagnostics":{"published_claims":22,"factual_claims":22,"claims_with_linked_evidence":22,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":16,"temporal_claims_with_valid_from":13,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-19T04:46:31.170154+00:00","observed_at":"2026-10-19T04:46:31.170154+00:00","reviewed_at":"2026-10-19T04:46:31.170154+00:00","verified_at":"2026-10-19T04:46:31.170154+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":22,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/gyre-therapeutics-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/gyre-therapeutics-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}